Acylated and alkylated histamine derivatives as new histamine H3-receptor antagonists

https://doi.org/10.1016/0223-5234(94)90031-0Get rights and content

Abstract

New histamine H3-receptor antagonists were prepared and investigated for their ability to increase synthesis and release of histamine mediated by inhibition of presynaptically located H3-receptors. Acyl derivatives of histamine methylated at different positions show poor activity at H3-receptors, whereas Nα-alkyl and particularly Nα-acyl derivatives of histamine possess moderate to good H3-receptor antagonist activity. A not-too-bulky and lipophilic residue in an optimal distance of 3–4 methylene groups from the amide function leads to potent and selective H3-receptor antagonists. Nα-Histamine-γ-phenylbutyramide II and Nα-histamine-γ-cyclohexylbutyramide 13 are H3-receptor antagonists with — log Ki of 7.1 and 7.3, respectively. Structure-activity relationships of different substitution patterns are discussed.

References (20)

  • M Garbarg et al.
  • JS Lin et al.

    Brain Res

    (1990)
  • JM Arrang et al.

    Nature (Lond)

    (1983)
  • E Schlicker et al.

    Naunyn-Schmiedeberg's Arch Pharmacol

    (1988)
  • J Clapham et al.

    Br J Pharmacol

    (1992)
  • GJ Molderings et al.

    Naunyn-Schmiedeberg's Arch Pharmacol

    (1992)
  • E Schlicker et al.

    J Neural Transm

    (1993)
  • R Lipp et al.
  • JM Arrang et al.

    Nature (Lond)

    (1987)
  • R Lipp et al.

    J Med Chem

    (1992)
There are more references available in the full text version of this article.

Cited by (0)

View full text